Medico Remedies Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Medico Remedies Limited Pharmaceutical Export Portfolio Dataset — 11 Products, $13.5M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Medico Remedies Limited — Pharmaceutical Exporter Profile (2026) | 11 Products, $13.5M Trade | TransData Nexus

Medico Remedies Limited

Indian Pharmaceutical Exporter · Antibiotics Specialist · $13.5M Total Trade · DGFT Verified

Medico Remedies Limited is an Indian pharmaceutical exporter with a total trade value of $13.5M across 11 products in 7 therapeutic categories. Based on 418 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Amoxicillin ($5.3M), Ampicillin ($2.0M), Acetaminophen ($1.4M).

Medico Remedies Limited — Export Portfolio & Destination Treemap

Medico Remedies Limited pharmaceutical export portfolio — 11 products across 7 therapeutic categories. Source: Indian Customs (DGFT).

Who is Medico Remedies Limited? — Company Overview & Market Position

Medico Remedies Limited, established in 1994, is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra, India, with its manufacturing facilities located in Palghar, Maharashtra. Medico Remedies Limited is a publicly listed entity on the Bombay Stock Exchange (BSE) under the ticker symbol 540937 and on the National Stock Exchange of India (NSE) under the ticker symbol MEDICO. The company's Corporate Identity Number (CIN) is L24230MH1994PLC077187. As of the latest available data, Medico Remedies Limited employs approximately 213 individuals. The company's annual turnover is estimated to be between 100 to 500 crore INR, reflecting its significant presence in the pharmaceutical industry.

What Does Medico Remedies Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Amoxicillin$5.3M 2Ampicillin$2.0M

Product Portfolio — Top 11 by Export Value

Medico Remedies Limited exports 11 pharmaceutical products across 7 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Amoxicillin	Antibiotics	$5.3M	108	0.9%	14
2	Ampicillin	Antibiotics	$2.0M	55	1.4%	12
3	Acetaminophen	Analgesics & Antipyretics	$1.4M	76	0.6%	14
4	Clarithromycin	Antibiotics	$1.3M	42	1.3%	12
5	Cefuroxime	Advanced Antibiotics	$1.1M	21	0.8%	14
6	Albendazole	Antimalarial & Antiparasitic	$1.0M	58	1.4%	14
7	Irbesartan	Cardiovascular	$800.0K	16	0.8%	10
8	Tinidazole	Advanced Antibiotics	$379.6K	13	2.1%	9
9	Ambroxol	Respiratory & OTC	$351.1K	21	2.4%	8
10	Prednisone	Respiratory	$31.6K	5	0.1%	13
11	Primaquine	Antimalarial & Antiparasitic	$19.1K	3	1.1%	12

Medico Remedies Limited exports 11 pharmaceutical products across 7 therapeutic categories with a total export value of $13.5M. The top category is Antibiotics (63.0% of portfolio), followed by Advanced Antibiotics (10.6%), indicating a concentrated portfolio with the top 5 products accounting for 80.9% of total export value.

Medico Remedies Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Medico Remedies Limited operates two state-of-the-art manufacturing units located in Palghar, Maharashtra. These facilities are equipped with advanced automated machinery, enabling the production of over 12 crore tablets and 4 crore capsules monthly. The company has recently expanded its operations to include an ointment manufacturing plant, which commenced trial production in May 2023. This new facility, covering 15,000 square feet, has the capacity to produce up to 3 million tubes monthly, thereby diversifying the company's product offerings.

3Key Leadership

The leadership team at Medico Remedies Limited comprises seasoned professionals with extensive experience in the pharmaceutical industry. Mr. Haresh Kapurlal Mehta serves as the Chairman and Chief Financial Officer, overseeing the financial and legal aspects of the company. He holds a Bachelor's Degree in Pharmacy from the University of Bombay and a diploma in Industrial Management from the Xavier Institute of Management, bringing approximately 39 years of experience to the role. Mr. Harshit Haresh Mehta, the Managing Director, leads the Marketing and Export departments. He holds a Bachelor's Degree in Pharmacy from the University of Mumbai and a Diploma in Family Business Management from the S.P. Jain Institute, Mumbai. Additionally, Mr. Rishit Hareshbhai Mehta serves as the Whole-Time Director and Head of Production, Technical, and Quality Control, contributing to the company's operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Medico Remedies Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Medico Remedies Limited has established a significant presence in various regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained approvals for its pharmaceutical formulations from regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. These approvals facilitate the export of Medico's products to these regions, ensuring compliance with stringent quality and safety standards. The company's adherence to Good Manufacturing Practices (GMP) and other regulatory requirements underscores its commitment to maintaining high-quality standards in its manufacturing processes.

2Emerging Markets

Medico Remedies Limited has strategically expanded its footprint into emerging markets across Africa, Latin America, and Southeast Asia. The company's products are exported to over 30 countries, including Myanmar, Vietnam, the Dominican Republic, Sri Lanka, the Philippines, Australia, Turkmenistan, Guyana, Ghana, Congo, Iraq, Honduras, Cuba, Hong Kong, Nigeria, Senegal, Panama, and Mozambique. This extensive distribution network is facilitated by the company's WHO-GMP certification, which ensures that its manufacturing processes meet international quality standards, thereby enabling access to these diverse markets.

Medico Remedies Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Medico Remedies Limited has registered its manufacturing facilities with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company has obtained approvals for its Abbreviated New Drug Applications (ANDAs), allowing it to market generic pharmaceutical formulations in the U.S. market. Additionally, Medico has filed Drug Master Files (DMFs) with the FDA, providing detailed information about the manufacturing processes and quality control measures for its products. The company's facilities have undergone FDA inspections, which have been completed satisfactorily, further affirming its commitment to maintaining high-quality manufacturing standards.

2WHO & EU GMP

Medico Remedies Limited holds certifications from the World Health Organization's Good Manufacturing Practices (WHO-GMP) and the European Union's Good Manufacturing Practices (EU GMP). These certifications validate the company's adherence to international quality standards in its manufacturing processes. The WHO-GMP certification, in particular, facilitates the company's access to various international markets, as it is recognized by regulatory authorities worldwide. The EU GMP certification further enhances the company's credibility and acceptance in the European market, ensuring that its products meet the stringent quality requirements set by the European Medicines Agency (EMA).

Medico Remedies Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Medico Remedies Limited operates in a competitive landscape with several key players in the pharmaceutical industry. In the generic pharmaceutical segment, companies such as Sun Pharmaceutical Industries and Torrent Pharmaceuticals are prominent competitors. These companies have established market shares and extensive distribution networks, posing competitive challenges to Medico Remedies Limited. However, Medico Remedies Limited differentiates itself through its focus on a diverse therapeutic portfolio, including anti-infectives, beta-lactams, cephalosporins, antimalarials, antiretrovirals, and anti-ulcer drugs. The company's adherence to international quality standards, as evidenced by its WHO-GMP and EU GMP certifications, further enhances its competitive position. Additionally, Medico Remedies Limited's strategic expansion into emerging markets provides growth opportunities that may not be fully capitalized upon by its competitors.

2Key Differentiators

Medico Remedies Limited's key differentiators include its comprehensive product portfolio, which spans various therapeutic categories such as anti-infectives, beta-lactams, cephalosporins, antimalarials, antiretrovirals, and anti-ulcer drugs. The company's commitment to quality is demonstrated through its WHO-GMP and EU GMP certifications, ensuring adherence to international manufacturing standards. Medico Remedies Limited's strategic focus on both regulated and emerging markets allows it to leverage growth opportunities across diverse regions. The recent expansion into the ointment manufacturing segment further diversifies its product offerings, catering to a broader range of patient needs.

Frequently Asked Questions — Medico Remedies Limited

How many pharmaceutical products does Medico Remedies Limited export from India?

Medico Remedies Limited exports 11 pharmaceutical products across 7 therapeutic categories. The top exports are Amoxicillin ($5.3M), Ampicillin ($2.0M), Acetaminophen ($1.4M), Clarithromycin ($1.3M), Cefuroxime ($1.1M). Total export value is $13.5M.

What is Medico Remedies Limited's total pharmaceutical export value?

Medico Remedies Limited's total pharmaceutical export value is $13.5M, based on 418 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Medico Remedies Limited cover?

Medico Remedies Limited exports across 7 therapeutic categories. The largest are Antibiotics (63.0%, 3 products), Advanced Antibiotics (10.6%, 2 products), Analgesics & Antipyretics (10.1%, 1 products).

Get Full Medico Remedies Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.